“We are going to Examine how the commercialization of the substance fits in with our enterprise design at Adastra in order to place ourselves to help the desire for a secure source of copyright,” reported Main executive officer Michael Forbes in a information launch. The corporate explained to VICE Information it wouldn't be commenting further.